prasugrel or ticagrelor

DRUG3 trials

Sponsors

Kaiser Franz Josef Hospital, Ludwig-Maximilians - University of Munich, University of Florida

Conditions

Acute Coronary SyndromeAtrial FibrillationCoronary Artery DiseaseCoronary Stent ImplantationPlatelet Inhibition

Phase 3

Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry

CompletedNCT01515345

Kaiser Franz Josef HospitalCoronary Stent Implantation, Platelet Inhibition

Start: 2011-07-31End: 2013-01-31Updated: 2017-04-25

Phase 4

Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI

CompletedNCT04981041

Ludwig-Maximilians - University of MunichAcute Coronary Syndrome, Atrial Fibrillation

Start: 2021-12-16End: 2026-05-30Updated: 2026-06-02

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

RecruitingNCT05681702

University of FloridaCoronary Artery Disease

Start: 2023-02-15End: 2027-03-31Target: 90Updated: 2026-03-09

Related Papers

Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial

Nature Medicine2026-08-29

Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry

BMJ Open2014-10-0126 citations